Antibody and Plasmablast Response to 13-Valent Pneumococcal Conjugate Vaccine in Chronic Lymphocytic Leukemia Patients – Preliminary Report

• Marcin Pasiarski,

  Affiliation Department of Hematology, Holycross Cancer Center, Kielce, Poland

  ⨯
• Jacek Rolinski ,

  * E-mail: jacek.rolinski@gmail.com

  Affiliations Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, Lublin, Poland, St. John’s Cancer Center, Lublin, Poland

  ⨯
• Ewelina Grywalska,

  Affiliations Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, Lublin, Poland, St. John’s Cancer Center, Lublin, Poland

  ⨯
• Agnieszka Stelmach-Goldys,

  Affiliation Department of Hematology, Holycross Cancer Center, Kielce, Poland

  ⨯
• Izabela Korona-Glowniak,

  Affiliation Department of Pharmaceutical Microbiology, Medical University of Lublin, Lublin, Poland

  ⨯
• Stanislaw Gozdz,

  Affiliations Department of Chemotherapy and Clinical Oncology, Holycross Cancer Center, Kielce, Poland, Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland

  ⨯
• Iwona Hus,

  Affiliation Department of Clinical Transplantology, Medical University of Lublin, Lublin, Poland

  ⨯
• Anna Malm

  Affiliation Department of Pharmaceutical Microbiology, Medical University of Lublin, Lublin, Poland

  ⨯